- Potentially Treatable Condition
- Body
- Osteoarthritis
- HOME
- ABOUT
- RESEARCH
- INSIGHTS & HAPPENINGS
- JOIN US
- CONTACT US
-
Menu
At Cell Tissue Technology Sdn Bhd, we offer a new treatment for Osteoarthritis (OA) that delivers health outcomes that many did not know were possible. Our treatment provides a more comprehensive OA treatment than conventional medicine therapies offer. It addresses both the symptoms and underlying causes of the condition in a way that conventional medicine treatments miss. We have developed a new product, CelltiMax, that can serve as an alternative to conventional medical treatments
The most typical type of arthritis is osteoarthritis (OA). Some people refer to it as “wear and tear” arthritis or degenerative joint disease. It usually affects the hands, hips, and knees. In OA, a joint’s cartilage starts to degrade and the underlying bone starts to alter. These alterations typically take time to manifest and worsen. OA may result in discomfort, stiffness, and edema. It can occasionally result in diminished function and disability as well.
OA symptoms frequently appear gradually and get worse with time. Signs and symptoms of OA include:
OA develops over time as the cartilage that protects the ends of your bones in your joints gradually wears down. Joint action is almost frictionless thanks to the hard, slick tissue known as cartilage.If the cartilage eventually totally deteriorates, the bone will eventually rub against the bone.
Although OA is sometimes referred to as a wear-and-tear condition, it also affects the entire joint in addition to the cartilage. The connective tissues that hold the joint together and connect muscle to bone deteriorates, and it alters the bone. In addition, it leads to joint lining irritation.
Medications can help relieve OA symptoms, primarily pain, including:
CelltiX is a type of extracellular vesicle from Umbilical Cord-Derived Mesenchymal Stem Cells (MSCs) manufactured in a cGMP-compliant facility.
It is a novel form of a major paracrine factor released by MSCs into a culture medium, which plays an important role in a wide range of biological processes.
CelltiMax is a product derived from human umbilical cord-derived Mesenchymal Stem Cells (MSCs). The cells are cultured, then administered to the patient via intramuscular or intravenous injection. They have the ability to differentiate into specialized cells with specific functions for various parts of the body, and can reduce inflammation, repair, renew, regenerate, and replace damaged cells.
One week before treatment:
If you believe that our treatment options may be able to improve your condition and enhance your quality of life, please contact us to schedule a complimentary consultation with one of our in-house clinical specialists. Our consultations are available in both Malay and English language.
Founded in 2010, Cell Tissue Group is a pioneering Malaysian medical technology company and a spin-off from the National University of Malaysia (UKM). As Malaysia’s first Tissue Engineering firm, Cell Tissue Group operates within a certified cGMP laboratory, ensuring the highest standards of medical research and product development, particularly in Tissue Engineering and Regenerative Medicine.
Founded in 2010, Cell Tissue Group is a pioneering Malaysian medical technology company and a spin-off from the National University of Malaysia (UKM). As Malaysia’s first Tissue Engineering firm, Cell Tissue Group operates within a certified cGMP laboratory, ensuring the highest standards of medical research and product development, particularly in Tissue Engineering and Regenerative Medicine.
Proudly powered by CTG © 2010-2024 Cell Tissue Group, a Universiti Kebangsaan Malaysia Spin-Off Company. – All Rights Reserved.